Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus

NCT00856284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2639

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Alogliptin
DRUG: Metformin
DRUG: Glipizide

Sponsor

Takeda